Citadel Advisors’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,465
Closed -$17.3K 14379
2024
Q4
$17.3K Buy
+3,465
New +$14.3K ﹤0.01% 13260
2024
Q2
Sell
-4,760
Closed -$25.7K 14144
2024
Q1
$25.7K Sell
4,760
-2,623
-36% -$14.4K ﹤0.01% 12828
2023
Q4
$49.4K Sell
7,383
-494
-6% -$5.69K ﹤0.01% 11790
2023
Q3
$92.4K Sell
7,877
-733
-9% -$14.4K ﹤0.01% 10995
2023
Q2
$152K Buy
8,610
+5,243
+156% +$127K ﹤0.01% 10318
2023
Q1
$107K Buy
3,367
+717
+27% +$36.2K ﹤0.01% 11161
2022
Q4
$144K Sell
2,650
-190
-7% -$11.8K ﹤0.01% 10671
2022
Q3
$261K Sell
2,840
-6,353
-69% -$566K ﹤0.01% 9865
2022
Q2
$695K Buy
9,193
+7,806
+563% +$471K ﹤0.01% 7886
2022
Q1
$97K Sell
1,387
-390
-22% -$44.2K ﹤0.01% 12309
2021
Q4
$374K Sell
1,777
-1,150
-39% -$287K ﹤0.01% 10403
2021
Q3
$764K Buy
2,927
+1,660
+131% +$404K ﹤0.01% 8832
2021
Q2
$366K Sell
1,267
-390
-24% -$130K ﹤0.01% 10783
2021
Q1
$665K Buy
+1,657
New +$750K ﹤0.01% 9052

Other funds holding ADN

Citadel Advisors's ADN Position: Q3 2025 in Review

Citadel Advisors sold out of Advent Technologies (ADN) in Q3 2025, closing a stake of 12,040 shares — an estimated $25.3K sold.

Citadel Advisors first reported a position in ADN in Q1 2021 and held it in 11 quarters. The position peaked at $816K in Q3 2021. 18 funds tracked by Wall St. Rank hold ADN as of Q3 2025.

  • Citadel Advisors reported no remaining Advent Technologies position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,040 Advent Technologies shares in Q3 2025, an estimated $25.3K.
  • Citadel Advisors first reported a position in Advent Technologies in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Advent Technologies position peaked at $816K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.